MedPath

se of MRI in gastric cancer for detecting spread of tumour in peritoneum

Not Applicable
Conditions
Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Registration Number
CTRI/2018/07/015012
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient with non-metastatic gastric cancer on baseline CECT who are planned for staging laparoscopy/ upfront surgery.

Exclusion Criteria

1.Patients who cannot undergo an optimal MRI

2.Patients who refuse consent for the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the sensitivity, specificity, and the positive and negative predictive value of MRI in detecting peritoneal disease in gastric cancer patients with non-metastatic disease on baseline CECT and correlate with staging laparoscopy findings/ upfront surgery.Timepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
Presence or absence of peritoneal disease on MRI compared to surgical findingsTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath